Scott Eastin
Psychiatry · Urbandale, IANPI 1417052861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2019 at $990 and has fallen 96.5% since, to $35 in 2024.
Across 123 payments — averaging $11.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$350
- Otsuka America Pharmaceutical, Inc.$235
- Vanda Pharmaceuticals Inc.$142
- Takeda Pharmaceuticals U.S.A., Inc.$116
- Shire North American Group Inc$109
- Johnson & Johnson$95
- plus $399 from 9 others
What the payments were for
- Food & beverage$1,41798%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $350 |
| Otsuka America Pharmaceutical, Inc. | 24 | $235 |
| Vanda Pharmaceuticals Inc. | 6 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $116 |
| Shire North American Group Inc | 10 | $109 |
| Johnson & Johnson | 6 | $95 |
| Sunovion Pharmaceuticals Inc. | 6 | $71 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Lundbeck LLC | 3 | $59 |
| Alkermes, Inc. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Bausch Health US, LLC | 3 | $36 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
How this compares
$1,447 in reported general payments places this provider in the 80th percentile of 245 psychiatry providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 33 | $2,120 |
| Bupropion XlBupropion Hcl | 47 | $1,294 |
| Duloxetine Hcl | 24 | $1,019 |
| Oxcarbazepine | 11 | $946 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $767 |
| Quetiapine Fumarate | 14 | $505 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $302 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $238 |
| Zolpidem Tartrate | 23 | $217 |
| Buspirone Hcl | 13 | $211 |
| Lorazepam | 28 | $160 |
| Lamotrigine | 12 | $158 |
| Trazodone Hcl | 19 | $154 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Urbandale
- Charles JennischUrbandale$949K
- Ara RobinsonUrbandale$817
- Manmohan SinghDes Moines$408K
- Jimmy MascaroOttumwa$361K
- Alan WhittersCedar Rapids$170K
- Donald BlackIowa City$19K
- William CoryellIowa City$18K
- Randall KavalierWest Des Moines$15K
- Dwight SchroederCedar Rapids$13K
- Rodney DeanSioux City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.